FDI in pharma grew 53% in H1
The Hindu
200% spurt on the back of demand for COVID products was seen in 20-21
Foreign direct investment (FDI) in the pharmaceutical sector in the first half (April-September) of this fiscal increased 53% to Rs.4,413 crore compared to the year earlier period.
The inflows continued to be buoyant, the Department of Economic Affairs said in the annual Economic Survey (2021-22) citing how FDI in pharmaceutical sector had witnessed a sudden spurt in 2020-21 showing a 200% increase over the previous fiscal.
More Related News